According to the news that Medical appointments for inherited breast cancer tests among women raised in the UK after Angelina Jolie declared her defensive mastectomy treatment.
A latest study suggests that the so-called “Angelina effect” led to the rise of breast cancer testing in the UK, which is definitely the impact of shock announcement made about women. Angelina took the decision after testing positive for the BRCA1 gene mutation that seriously enhances the possibility of increasing the disease and the study shows that medical appointment breast cancer testing continued to rise even until October 2013.
The process of Mastectomy is the limited or absolute removal of a person’s breast to cure cancer and the double mastectomy is the surgical elimination of both the breasts. An individual can choose for mastectomy as a defensive measure to decrease the possibility of breast cancer.
Angelina Jolie declared that she will go through defensive double mastectomy because she has a family record of breast cancer. Scientists propose that the BRCA1 gene mutation is usually inherited from a parent and the actress’s mother suffered from breast cancer.
The actress decision supported several women to get them checked by the doctors for breast cancer. Records available from 21 clinics propose more women in the UK approached their doctors after Jolie’s statement. The study also emphasized that the majority of the women who wanted to be examined for breast cancer had a family record of the disease.
The professor of clinical genetics Gareth Evans, who led the investigate, recommends that Jolie’s announcement had a long-term effect and he also estimated data gathered from 12 family history clinics and 9 regional genetic centers across the UK.
He also stated that this step will help to lessened patients’ fears about a loss of sexual characteristics after preventive surgery and encouraged those who had not previously connected with health services to consider genetic testing and It’s important to keep in mind that only one in five breast cancer cases are associated with having a family history of the disease, and faults in recognized breast cancer genes are very unusual.